These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Fluoxetine exposures: are they safe for children? Baker SD; Morgan DL Am J Emerg Med; 2004 May; 22(3):211-3. PubMed ID: 15138960 [TBL] [Abstract][Full Text] [Related]
23. Electronic Cigarette Toxicity. Payne JD; Michaels D; Orellana-Barrios M; Nugent K J Prim Care Community Health; 2017 Apr; 8(2):100-102. PubMed ID: 27650036 [TBL] [Abstract][Full Text] [Related]
24. A retrospective evaluation of analgesic exposures from Izmir, Turkey. Hocaoglu N; Kalkan S; Akgun A; Capar S; Tuncok Y Hum Exp Toxicol; 2007 Aug; 26(8):629-36. PubMed ID: 17884950 [TBL] [Abstract][Full Text] [Related]
25. Transdermal drug delivery system exposure outcomes. Roberge RJ; Krenzelok EP; Mrvos R J Emerg Med; 2000 Feb; 18(2):147-51. PubMed ID: 10699513 [TBL] [Abstract][Full Text] [Related]
26. A retrospective review of isolated gliptin-exposure cases reported to a state poison control system. Darracq MA; Toy JM; Chen T; Mo C; Cantrell FL Clin Toxicol (Phila); 2014 Mar; 52(3):226-30. PubMed ID: 24580063 [TBL] [Abstract][Full Text] [Related]
27. 2011 Annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 29th Annual Report. Bronstein AC; Spyker DA; Cantilena LR; Rumack BH; Dart RC Clin Toxicol (Phila); 2012 Dec; 50(10):911-1164. PubMed ID: 23272763 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of toxicity of topiramate exposures reported to poison centers. Lofton AL; Klein-Schwartz W Hum Exp Toxicol; 2005 Nov; 24(11):591-5. PubMed ID: 16323576 [TBL] [Abstract][Full Text] [Related]
34. Pesticide-related poison center exposures in children and adolescents aged ≤19 years in Texas, 2000-2013. Trueblood AB; Forrester MB; Han D; Shipp EM; Cizmas LH Clin Toxicol (Phila); 2016 Nov; 54(9):852-856. PubMed ID: 27352113 [TBL] [Abstract][Full Text] [Related]
35. Human bromethalin exposures reported to a U.S. Statewide Poison Control System. Huntington S; Fenik Y; Vohra R; Geller RJ Clin Toxicol (Phila); 2016 Mar; 54(3):277-81. PubMed ID: 26860212 [TBL] [Abstract][Full Text] [Related]
36. Characterization of edible marijuana product exposures reported to United States poison centers. Cao D; Srisuma S; Bronstein AC; Hoyte CO Clin Toxicol (Phila); 2016 Nov; 54(9):840-846. PubMed ID: 27418198 [TBL] [Abstract][Full Text] [Related]
37. Colchicine exposures: the Texas experience. Levsky ME; Miller MA; Masneri DA; Borys D South Med J; 2008 May; 101(5):480-3. PubMed ID: 18414172 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of cosmetic product exposures reported to the Milan Poison Control Centre, Italy from 2005 to 2010. Ruggiero S; Moro PA; Davanzo F; Capuano A; Rossi F; Sautebin L Clin Toxicol (Phila); 2012 Dec; 50(10):902-10. PubMed ID: 23134375 [TBL] [Abstract][Full Text] [Related]
39. Pattern of orlistat exposures in children aged 5 years or less. Forrester MB J Emerg Med; 2009 Nov; 37(4):396-9. PubMed ID: 18403165 [TBL] [Abstract][Full Text] [Related]
40. A retrospective poison center review of varenicline-exposed patients. Kreshak AA; Clark AK; Clark RF; Ly BT; Cantrell FL Ann Pharmacother; 2009 Dec; 43(12):1986-91. PubMed ID: 19934384 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]